The neurovascular protective effect of alogliptin in murine MCAO model and brain endothelial cells
Endothelial damage and blood brain barrier disruption contribute to ischemic stroke and brain injury. Gliptins are a novel class of treatment agents for diabetes, and recent studies have linked the use of gliptins to neuroprotection. Alogliptin is a type of orally available gliptin that was approved...
Main Authors: | Feng-li Hao, Xiao-fang Han, Xiao-li Wang, Zhi-ru Zhao, Ai-hong Guo, Xin-jian Lu, Xiong-fei Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218339064 |
Similar Items
-
CARDIOVASCULAR SAFETY OF GLIPTINS. FOCUS ON ALOGLIPTIN
by: N. A. Petunina, et al.
Published: (2017-12-01) -
Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non- diabetic subjects: a preliminary report
by: Noda Yoko, et al.
Published: (2013-01-01) -
Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial
by: João Pedro Ferreira, et al.
Published: (2020-06-01) -
Salting-out induced liquid–liquid microextraction for alogliptin benzoate determination in human plasma by HPLC/UV
by: Sherin F. Hammad, et al.
Published: (2021-01-01) -
Synthesis of a novel analogue of DPP-4 inhibitor Alogliptin: Introduction of a spirocyclic moiety on the piperidine ring
by: Arumugam Kodimuthali, et al.
Published: (2010-07-01)